Now showing items 1-2 of 2

    • Roco, Ángela; Nieto, Elena; Suárez, Marcelo; Rojo, Mario; Bertoglia, María Paz; Verón, Gabriel; Tamayo, Francisca; Arredondo, Annabella; Cruz, Daniela; Muñoz, Jessica; Bravo, Gabriela; Salas, Patricio; Mejías, Fanny; Godoy, Gerald; Véliz, Paulo; Quiñones Sepúlveda, Luis (Frontiers Media, 2020)
      Background Vitamin K antagonists (VKA) are used as prophylaxis for thromboembolic events in patients with cardiovascular diseases. The most common VKA are warfarin and acenocoumarol. These drugs have a narrow therapeutic ...
    • Rojo, Mario; Roco Arriagada, Ángela; Suárez, Marcelo; Lavanderos Villagrán, María Alejandra; Verón, Gabriel; Bertoglia Arredondo, María Paz; Arredondo, Annabella; Nieto, Elena; Rubilar, Juan Carlos; Tamayo, Francisca; Cruz, Daniela; Muñóz, Jessica; Bravo, Gabriela; Salas, Patricio; Mejías, Fanny; Véliz, Paulo; Godoy, Gerald; Varela Figueroa, Nelson; Llull, G.; Quiñones Sepúlveda, Luis (SAGE, 2020)
      Despite the development of new oral agents over the last decade, vitamin K antagonists (VKAs) remain the most widely used anticoagulants for treating and preventing thromboembolism worldwide. In Chile, the Ministry of ...